A CHIMERIC RECEPTOR ENABLING ANTIBODY-GUIDED RETARGETING OF CAR T- CELLS
Natasha Vinanica, J Q Yeo, Nurul Ain Nisrina Hamran, Dario Campana
This paper introduces a chimeric receptor (CARFcR) that combines CAR-T cell potency with antibody targeting, enabling effective cytotoxicity against both CD19+ and CD19- tumor cells using approved antibodies.
bioRxiv · Apr 29, 2026 · PreprintBioengineering